Long term development of gut microbiota composition in atopic children: Impact of probiotics

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Rutten, N B M M ^a,b   Gorissen, D M W ^a   Eck, A ^c   Niers, L E M ^a,g   Vlieger, A M ^b   Besseling Van Der Vaart, I ^d   Budding, A E ^c   Savelkoul, P H M ^c,e   Van Der Ent, C K ^a   Rijkers, G T ^b,f  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ST ANTONIUS HOSPITAL   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d WINCLOVE PROBIOTICS   (Netherlands)

^e MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^f Roosevelt Academy   (Netherlands)

^g MÁXIMA MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ECOLOGIC; PROBIOTIC AGENT; UNCLASSIFIED DRUG; PLACEBO; RNA 16S; RNA 23S;

ACTINOBACTERIA; ARTICLE; ATOPIC DERMATITIS; ATOPY; BACTEROIDETES; BIFIDOBACTERIUM ANIMALIS; BIFIDOBACTERIUM BIFIDUM; CHILD; COLONY FORMING UNIT; CONTROLLED STUDY; DENATURING GRADIENT GEL ELECTROPHORESIS; DISCRIMINANT ANALYSIS; DOUBLE BLIND PROCEDURE; FECES ANALYSIS; FIRMICUTES; FLUORESCENCE IN SITU HYBRIDIZATION; FOLLOW UP; FUSOBACTERIA; HUMAN; IMMUNE RESPONSE; INFANT; INTESTINE FLORA; LACTOCOCCUS LACTIS; MAJOR CLINICAL STUDY; NEWBORN; POPULATION ABUNDANCE; PREGNANT WOMAN; PRESCHOOL CHILD; PROTEOBACTERIA; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SPECIES DIVERSITY; VERRUCOMICROBIA; BACTERIUM IDENTIFICATION; BIFIDOBACTERIUM; BIODIVERSITY; DIETARY SUPPLEMENT; DRUG EFFECTS; FEMALE; GENETICS; HYPERSENSITIVITY; IMMUNOLOGY; LACTOBACILLUS; MALE; METAGENOME; PREGNANCY;

BACTERIAL TYPING TECHNIQUES; BIFIDOBACTERIUM; BIODIVERSITY; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL MICROBIOME; HUMANS; HYPERSENSITIVITY; INFANT; INFANT, NEWBORN; LACTOBACILLUS; MALE; METAGENOME; PLACEBOS; PREGNANCY; PROBIOTICS; RNA, RIBOSOMAL, 16S; RNA, RIBOSOMAL, 23S;

EID: 84945547238     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137681     Document Type: Article

References (36)

1. Makino H, Kushiro A, Ishikawa E, Kubota H, Gawad A, Sakai T, et al. Mother-to-infant transmission of intestinal bifidobacterial strains has an impact on the early development of vaginally delivered infant's microbiota. PLoS One. 2013; 8: e78331. doi: 10.1371/journal.pone.0078331 PMID: 24244304
2. Bisgaard H, Li N, Bonnelykke K, Chawes BLK, Skov T, Paludan-Müller G, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011; 128: 646-52.e1-5. doi: 10.1016/j.jaci.2011.04.060 PMID: 21782228
3. Li M, Wang M, Donovan SM. Early development of the gut microbiome and immune-mediated childhood disorders. Semin Reprod Med. 2014; 32: 74-86. doi: 10.1055/s-0033-1361825 PMID: 24390924
4. Ringel-Kulka T, Cheng J, Ringel Y, Salojärvi J, Carroll I, Palva A, et al. Intestinal microbiota in healthy U.S. young children and adults - A high throughput microarray analysis. PLoS One. 2013; 8: e64315. doi: 10.1371/journal.pone.0064315 PMID: 23717595
5. Nylund L, Satokari R, Nikkilä J, Rajilić-Stojanović M, Kalliomäki M, Isolauri E, et al. Microarray analysis reveals marked intestinal microbiota aberrancy in infants having eczema compared to healthy children in at-risk for atopic disease. BMC Microbiol. 2013; 13: 12. doi: 10.1186/1471-2180-13-12 PMID: 23339708
6. Fouhy F, Ross RP, Fitzgerald G, Stanton C, Cotter PD, Food E, et al. Knowledge, knowledge gaps and the use of high-throughput sequencing to address these gaps © 2012 Landes Bioscience. 2012; 203-220.
7. Wang M, Karlsson C, Olsson C, Adlerberth I, Wold AE, Strachan DP, et al. Reduced diversity in the early fecal microbiota of infants with atopic eczema. J Allergy Clin Immunol. 2008; 121: 129-34. doi: 10. 1016/j.jaci.2007.09.011 PMID: 18028995
8. Nylund L, Nermes M, Isolauri E, Salminen S, de Vos WM, Satokari R. Severity of atopic disease inversely correlates with intestinal microbiota diversity and butyrate-producing bacteria. Allergy. 2014; 70: 241-244. doi: 10.1111/all.12549
9. Abrahamsson TR, Jakobsson HE, Andersson AF, Björkstén B, Engstrand L, Jenmalm MC. Low diversity of the gut microbiota in infants with atopic eczema. J Allergy Clin Immunol. 2012; 129: 434-40, 440. e1-2. doi: 10.1016/j.jaci.2011.10.025 PMID: 22153774
10. Kirjavainen P V, Arvola T, Salminen SJ, Isolauri E. Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning? Gut. 2002; 51: 51-5. Available: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=1773282&tool = pmcentrez&rendertype = abstract. PMID: 12077091
11. Niers L, Martín R, Rijkers G, Sengers F, Timmerman H, van Uden N, et al. The effects of selected probiotic strains on the development of eczema (the PandA study). Allergy. 2009; 64: 1349-58. doi: 10. 1111/j.1398-9995.2009.02021.x PMID: 19392993
12. Cox MJ, Huang YJ, Fujimura KE, Liu JT, McKean M, Boushey H a, et al. Lactobacillus casei abundance is associated with profound shifts in the infant gut microbiome. PLoS One. 2010; 5: e8745. doi: 10. 1371/journal.pone.0008745 PMID: 20090909
13. Nermes M, Kantele JM, Atosuo TJ, Salminen S, Isolauri E. Interaction of orally administered Lactobacillus rhamnosus GG with skin and gut microbiota and humoral immunity in infants with atopic dermatitis. Clin Exp Allergy. 2011; 41: 370-7. doi: 10.1111/j.1365-2222.2010.03657.x PMID: 21121981
14. Enomoto T, Sowa M, Nishimori K, Shimazu S, Yoshida A, Yamada K, et al. Effects of bifidobacterial supplementation to pregnant women and infants in the prevention of allergy development in infants and on fecal microbiota. Allergol Int. 2014; 63: 575-85. doi: 10.2332/allergolint.13-OA-0683 PMID: 25056226
15. Lahtinen SJ, Boyle RJ, Kivivuori S, Oppedisano F, Smith KR, Robins-Browne R, et al. Prenatal probiotic administration can influence Bifidobacterium microbiota development in infants at high risk of allergy. J Allergy Clin Immunol. 2009; 123: 499-501. doi: 10.1016/j.jaci.2008.11.034 PMID: 19135234
16. Pelucchi C, Chatenoud L, Turati F, Galeone C, Moja L, Bach J-F, et al. Probiotics supplementation during pregnancy or infancy for the prevention of atopic dermatitis: a meta-analysis. Epidemiology. 2012; 23: 402-14. doi: 10.1097/EDE.0b013e31824d5da2 PMID: 22441545
17. Boyle RJ, Bath-Hextall FJ, Leonardi-Bee J, Murrell DF, Tang MLK. Probiotics for treating eczema. Cochrane Database of Systematic Reviews. 2008. doi: 10.1002/14651858.CD006135.pub2
18. Boyle RJ, Tang MLK. The Role of Probiotics in the Management of Allergic Disease Clinical and Experimental Allergy. 2006; 568-576. PMID: 16650040
19. Elazab N, Mendy A, Gasana J, Vieira ER, Quizon A, Forno E. Probiotic administration in early life, atopy, and asthma: a meta-analysis of clinical trials. Pediatrics. 2013; 132: e666-76. doi: 10.1542/peds.2013-0246 PMID: 23958764
20. Bezirtzoglou E, Stavropoulou E. Immunology and probiotic impact of the newborn and young children intestinal microflora. Anaerobe. Elsevier Ltd; 2011; 17: 369-74. doi: 10.1016/j.anaerobe.2011.03.010 PMID: 21515397
21. Osborn DA, Sinn JKH. Probiotics in infants for prevention of allergic disease and food hypersensitivity (Review). Cochrane Database Syst Rev. 2007; Available: http://www.ncbi.nlm.nih.gov/pubmed/17943912.
22. Gorissen DMW, Rutten NBMM, Oostermeijer CMJ, Niers LEM, Hoekstra MO, Rijkers GT, et al. Preventive effects of selected probiotic strains on the development of asthma and allergic rhinitis in childhood. The Panda-study. Clin Exp Allergy. 2014; doi: 10.1111/cea.12413
23. Budding a E, Grasman ME, Lin F, Bogaards J a, Soeltan-Kaersenhout DJ, Vandenbroucke-Grauls CMJE, et al. IS-pro: high-throughput molecular fingerprinting of the intestinal microbiota. FASEB J. 2010; 24: 4556-64. doi: 10.1096/fj.10-156190 PMID: 20643909
24. D'Haeseleer P. How does gene expression clustering work? Nat Biotechnol. 2005; 23: 1499-501. doi: 10.1038/nbt1205-1499 PMID: 16333293
25. Haegeman B, Hamelin J, Moriarty J, Neal P, Dushoff J, Weitz JS. Robust estimation of microbial diversity in theory and in practice. ISME J. 2013; 7: 1092-101. doi: 10.1038/ismej.2013.10 PMID: 23407313
26. Segata N, Izard J, Waldron L, Gevers D, Miropolsky L, Garrett WS, et al. Metagenomic biomarker discovery and explanation. Genome Biol. BioMed Central Ltd; 2011; 12: R60. doi: 10.1186/gb-2011-12-6-r60 PMID: 21702898
27. Palmer C, Bik EM, DiGiulio DB, Relman D a, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol. 2007; 5: e177. doi: 10.1371/journal.pbio.0050177 PMID: 17594176
28. Clemente JC, Ursell LK, Parfrey LW, Knight R. The impact of the gut microbiota on human health: an integrative view. Cell. Elsevier Inc.; 2012; 148: 1258-70. doi: 10.1016/j.cell.2012.01.035 PMID: 22424233
29. Koenig JE, Spor A, Scalfone N, Fricker AD, Stombaugh J, Knight R, et al. Succession of microbial consortia in the developing infant gut microbiome. Proc Natl Acad Sci U S A. 2011; 108 Suppl: 4578-85. doi: 10.1073/pnas.1000081107 PMID: 20668239
30. Yatsunenko T, Rey FE, Manary MJ, Trehan I, Dominguez-Bello MG, Contreras M, et al. Human gut microbiome viewed across age and geography. Nature. 2012; 486: 222-7. doi: 10.1038/nature11053 PMID: 22699611
31. Kolokotroni O, Middleton N, Gavatha M, Lamnisos D, Priftis KN, Yiallouros PK. Asthma and atopy in children born by caesarean section: effect modification by family history of allergies - A population based cross-sectional study. BMC Pediatr. 2012; 12: 179. doi: 10.1186/1471-2431-12-179 PMID: 23153011
32. Kalliomäki M, Antoine J-M, Herz U, Rijkers GT, Wells JM, Mercenier A. Guidance for substantiating the evidence for beneficial effects of probiotics: prevention and management of allergic diseases by probiotics. J Nutr. 2010; 140: 713S-21S. doi: 10.3945/jn.109.113761 PMID: 20130079
33. Ismail IH, Oppedisano F, Joseph SJ, Boyle RJ, Licciardi P V, Robins-Browne RM, et al. Reduced gut microbial diversity in early life is associated with later development of eczema but not atopy in high-risk infants. Pediatr Allergy Immunol. 2012; 23: 674-81. doi: 10.1111/j.1399-3038.2012.01328.x PMID: 22831283
34. Adlerberth I, Strachan DP, Matricardi PM, Ahrné S, Orfei L, Aberg N, et al. Gut microbiota and development of atopic eczema in 3 European birth cohorts. J Allergy Clin Immunol. 2007; 120: 343-50. doi: 10. 1016/j.jaci.2007.05.018 PMID: 17604093
35. Arpaia N, Campbell C, Fan X, Dikiy S, van der Veeken J, deRoos P, et al. Metabolites produced by commensal bacteria promote peripheral regulatory T-cell generation. Nature. 2013; 504: 451-5. doi: 10.1038/nature12726 PMID: 24226773
36. Furusawa Y, Obata Y, Fukuda S, Endo TA, Nakato G, Takahashi D, et al. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells. Nature. 2013; 504: 446-50. doi: 10. 1038/nature12721 PMID: 24226770